BindingDB logo
myBDB logout

27 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27994731 3 Identification of Triptophenolide fromEBI Chinese Academy of Medical Science
23403082 28 Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.EBI Broad Institute of MIT and Harvard
23466225 2 Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer.EBI AstraZeneca
16134935 119 Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.EBI University of Basel
17606915 4 Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs.EBI The Scripps Research Institute
16942875 32 A bioisosteric approach to the discovery of indole carbinol androgen receptor ligands.EBI Johnson and Johnson Pharmaceutical Research and Development L.L.C.
16603353 26 Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.EBI Johnson& Johnson Pharmaceutical Research and Development
15454212 16 Synthesis and structure-activity investigation of iodinated arylhydantoins and arylthiohydantoins for development as androgen receptor radioligands.EBI The University of Michigan Medical School
11101354 18 Chiral derivatives of 2-cyclohexylideneperhydro-4,7-methanoindenes, a novel class of nonsteroidal androgen receptor ligand: synthesis, X-ray analysis, and biological activity.EBI The University of Sydney
10966753 5 Design, synthesis, and pharmacological characterization of 4-[4, 4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl]- 2-iodobenzonitrile as a high-affinity nonsteroidal androgen receptor ligand.EBI The University of Michigan Medical School
1588549 9 Antiandrogenic steroidal sulfonyl heterocycles. Utility of electrostatic complementarity in defining bioisosteric sulfonyl heterocycles.EBI Sterling Winthrop Pharmaceuticals Research Division
3783591 130 Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding.EBI TBA
11327585 15 Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands.EBI The University of Michigan Medical School
21944856 51 Tetrahydroquinolines as a novel series of nonsteroidal selective androgen receptor modulators: structural requirements for better physicochemical and biological properties.EBI Kaken Pharmaceutical Co., Ltd
21349712 15 Design and synthesis of tricyclic tetrahydroquinolines as a new series of nonsteroidal selective androgen receptor modulators (SARMs).EBI Kaken Pharmaceutical Co., Ltd
17328524 1 Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging.EBI University of Illinois
17149866 4 Identification of the brominated flame retardant 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane as an androgen agonist.EBI Orebro University
15784656 15 Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.BDB Abbott Laboratories
15743919 14 Endocrinological properties of two novel nonsteroidal progesterone receptor modulators, CP8816 and CP8863.BDB Meiji Seika Kaisha, Ltd.
18805694 8 Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.BDB The Ohio State University
16828557 19 Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer.BDB University of Tennessee Health Science Center
9514878 7 Discovery of nonsteroidal androgens.BDB University of Tennessee at Memphis
10691684 20 Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.BDB University of Tennessee at Memphis
14761201 16 Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators.BDB University of Tennessee at Memphis
16420057 33 (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.BDB Astellas Pharma Inc.